CM
MDT icon

CastleKnight Management’s Medtronic MDT Stock Holding History

CastleKnight Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,100
Closed -$361K – 335
2023
Q2 		$361K Buy
+4,100
New +$353K 0.04% 233

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CastleKnight Management's MDT Position: Q3 2023 in Review

CastleKnight Management sold out of Medtronic (MDT) in Q3 2023, closing a stake of 4,100 shares — an estimated $361K sold.

CastleKnight Management first reported a position in MDT in Q2 2023 and held it in 1 quarter. The position peaked at $361K in Q2 2023. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • CastleKnight Management reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
  • CastleKnight Management sold 4,100 Medtronic shares in Q3 2023, an estimated $361K.
  • CastleKnight Management first reported a position in Medtronic in Q2 2023 and held it in 1 quarter.
  • CastleKnight Management's Medtronic position peaked at $361K in Q2 2023.
  • 1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on CastleKnight Management's 13F filing for Q3 2023, filed 14 Nov 2023.